Guardion Health Sciences Statistics
Share Statistics
Guardion Health Sciences has 1.35M
shares outstanding. The number of shares has increased by 5.12%
in one year.
| Shares Outstanding | 1.35M |
| Shares Change (YoY) | 5.12% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 22.26K, so undefined% of the outstanding
shares have been sold short.
| Short Interest | 22.26K |
| Short % of Shares Out | n/a |
| Short % of Float | 1.92% |
| Short Ratio (days to cover) | 0.18 |
Valuation Ratios
The PE ratio is 42.94 and the forward
PE ratio is -3.16.
Guardion Health Sciences's PEG ratio is
-0.43.
| PE Ratio | 42.94 |
| Forward PE | -3.16 |
| PS Ratio | 0.55 |
| Forward PS | 0.3 |
| PB Ratio | 0.83 |
| P/FCF Ratio | -1.55 |
| PEG Ratio | -0.43 |
Financial Ratio HistoryEnterprise Valuation
Guardion Health Sciences has an Enterprise Value (EV) of 426.67K.
| EV / Sales | 0.03 |
| EV / EBITDA | -0.11 |
| EV / EBIT | -0.1 |
| EV / FCF | -0.1 |
Financial Position
The company has a current ratio of 9.01,
with a Debt / Equity ratio of 0.
| Current Ratio | 9.01 |
| Quick Ratio | 6.98 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 1.94% and Return on Invested Capital is -40.91%.
| Return on Equity | 1.94% |
| Return on Assets | 1.33% |
| Return on Invested Capital | -40.91% |
| Revenue Per Employee | $1,360,950 |
| Profits Per Employee | $17,559.22 |
| Employee Count | 9 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 2.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -63.28% in the
last 52 weeks. The beta is 0.71, so Guardion Health Sciences's
price volatility has been higher than the market average.
| Beta | 0.71 |
| 52-Week Price Change | -63.28% |
| 50-Day Moving Average | 3.22 |
| 200-Day Moving Average | 5.8 |
| Relative Strength Index (RSI) | 25.77 |
| Average Volume (20 Days) | 34,154 |
Income Statement
In the last 12 months, Guardion Health Sciences had revenue of 12.25M
and earned 158.03K
in profits. Earnings per share was 0.12.
| Revenue | 12.25M |
| Gross Profit | 5.39M |
| Operating Income | -4.34M |
| Net Income | 158.03K |
| EBITDA | -3.92M |
| EBIT | -3.94M |
| Earnings Per Share (EPS) | 0.12 |
Full Income StatementBalance Sheet
The company has 6.36M in cash and 0 in
debt, giving a net cash position of 6.36M.
| Cash & Cash Equivalents | 6.36M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -93.57M |
| Total Assets | 15.3M |
| Working Capital | 14.37M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -4.37M
and capital expenditures -3.79K, giving a free cash flow of -4.37M.
| Operating Cash Flow | -4.37M |
| Capital Expenditures | -3.79K |
| Free Cash Flow | -4.37M |
| FCF Per Share | -3.44 |
Full Cash Flow StatementMargins
Gross margin is 44.04%, with operating and profit margins of -35.4% and 1.29%.
| Gross Margin | 44.04% |
| Operating Margin | -35.4% |
| Pretax Margin | 1.29% |
| Profit Margin | 1.29% |
| EBITDA Margin | -32.02% |
| EBIT Margin | -35.4% |
| FCF Margin | -35.71% |
